These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16845932)

  • 1. [The effect of hypokinesia on depression and on the central GABA-A receptor complexes in the rat brain].
    Akopian VP; Balian LS; Avetisian NA
    Eksp Klin Farmakol; 2006; 69(2):10-3. PubMed ID: 16845932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of nootropes on quantitative changes in the rat cerebral cortex GABA(A) receptor complexes under experimental hypokinesia conditions].
    Akopian VP; Balian LS; Zakarian NA
    Eksp Klin Farmakol; 2010 Jul; 73(7):13-5. PubMed ID: 20821973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of GABA and piracetam on the qualitative and quantitative composition of the brain phospholipids in rats under hypokinetic conditions].
    Akopian VP; Sotskiĭ OP; Oveian GA; Edigarova LV
    Eksp Klin Farmakol; 1996; 59(3):40-3. PubMed ID: 8974583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of GABA and pyracetam on mitochondrial ADP phosphorylation in experimental hypokinesia].
    Sotskiĭ OP; Akopian VP; Zhamgarian LG; Zhamgarian AG
    Vopr Med Khim; 2002; 48(5):485-9. PubMed ID: 12498091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of GABA-ergic agents on the electrolyte balance under hypokinesia].
    Akopian VP; Edigarova LV
    Eksp Klin Farmakol; 1998; 61(5):62-4. PubMed ID: 9854639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of GABA and piracetam on on ATPase activity in brain and liver mitochondria in experimental hypokinesis].
    Akopian VP; Sotskiĭ OP; Mailian KR; Edigarova LV; Shafrazian DS; Vasilian AA
    Vopr Med Khim; 1998; 44(3):262-6. PubMed ID: 9703626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical prognosis of pyracetam and picamilon safety based on acute toxicity data].
    Bugaeva LI; Spasov AA; Verovskiĭ VE; Iezhitsa IN
    Eksp Klin Farmakol; 2003; 66(4):43-6. PubMed ID: 14558352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GABA-ergic cortical component in the action of piracetam and cetyl GABA].
    Ostrovskaia RU; Molodavkin GM; Kovalev GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):62-4. PubMed ID: 7082805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon].
    Kuchmerovskaia TM; Parkhomets PK; Donchenko GV; Obrosova IG; Klimenko AP; Kuchmerovskiĭ NA; Pakirbaeva LV; Efimov AS
    Vopr Med Khim; 1998; 44(6):559-64. PubMed ID: 10599142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of the nootropic drugs].
    Boĭko SS; Vitskova GIu; Zherdev VP
    Eksp Klin Farmakol; 1997; 60(6):62-70. PubMed ID: 9460604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
    Amroian EA; Vartazarian ND; Parsamian LK; Balian LS
    Biull Eksp Biol Med; 1990 Aug; 110(8):124-7. PubMed ID: 2127234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Relative specificity for 3H-glutamate sites.
    Bering B; Müller WE
    Arzneimittelforschung; 1985; 35(9):1350-2. PubMed ID: 3002398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GABA reuptake by rat brain slices in hypokinesia and under the influence of cinnarizine and flunarizine].
    Mirzoian NR; Akopian VP; Kocharian AZh; Knarian VA; Arakelian LN; Gevorkian GA
    Eksp Klin Farmakol; 1998; 61(5):15-7. PubMed ID: 9854625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of GABA on phosphoinositide cycle and membrane lipid modification in the brain synaptosomes of rats in hypokinesia].
    Akopian VP; Melkonian KV; Tadevosian IuV; Batikian TB
    Eksp Klin Farmakol; 2003; 66(5):6-9. PubMed ID: 14650205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Participation of GABA--benzodiazepine receptor complex in the anxiolytic effect of piracetam].
    Moldavkin GM; Voronina TA; Neznamov GG; Maletova OK; Eliava NV
    Eksp Klin Farmakol; 2006; 69(3):7-9. PubMed ID: 16878489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
    Pollack MH; Jensen JE; Simon NM; Kaufman RE; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):739-43. PubMed ID: 18206286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of piracetam on behavior and brain receptors in C57BL/6 and BALB/c mice: nootropic and anxiolytic effects].
    Kovalev GI; Kondrakhin EA; Salimov RM; Neznamov GG
    Eksp Klin Farmakol; 2013; 76(9):3-10. PubMed ID: 24432561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various aspects of increased resistance of the brain tissue and its vessels to extreme effects with the use of GABAergic compounds and Ca(2+) antagonists].
    Akopian VP; Melkonian KV; Samvelian VM; Shirinian EA; Mirzoian NR
    Eksp Klin Farmakol; 1997; 60(5):31-4. PubMed ID: 9483402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of benzodiazepine and GABA derivatives on the energy metabolism indices in brain edema].
    Novikov VE; Kozlov SN; Iasnetsov VS
    Farmakol Toksikol; 1984; 47(3):35-8. PubMed ID: 6145621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional-behavioral profile of new cyclic GABA analogs in acute toxicity tests].
    Bugaeva LI; Spasov AA; Verovskiĭ VE
    Eksp Klin Farmakol; 2004; 67(3):61-5. PubMed ID: 15341073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.